Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa

AIDS

Volumn 13, Issue 12, 1999, Pages 1543-1547

  Connolly, Cathy ^c   Reid, Alasdair ^c   Davies, Gerry ^c   Sturm, Willem ^a   McAdam, Keith P W J ^c   Wilkinson, David ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c NONE

Author keywords

Directly observed therapy; HIV; Mortality rate; Rural Africa; Tuberculosis; Tuberculosis relapse

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROBABILITY; RELAPSE; RURAL AREA; SOUTH AFRICA; SURVIVAL; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COHORT STUDIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PROBABILITY; RECURRENCE; RURAL HEALTH; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 0032820253     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199908200-00015     Document Type: Article

References (14)

1. Maher D, Hausler HP, Raviglione MC, et al. Tuberculosis care in community care organisations in sub-Saharan Africa: practice and potential. Int J Tuberculosis Lung Dis 1997;1:276-283.
2. De Cock KM, Wilkinson D. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet 1995;346:675-677.
3. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet 1994;343:647-648.
4. Wilkinson D, Davies GR, Connolly C. Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994. Am J Public Health 1996;86:1094-1097.
5. Floyd K, Wilkinson D, Gilks CF. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997;315:1407-1411.
6. Davies G, Connolly C, Sturm A, McAdam K, Wilkinson D. Twice weekly, directly observed treatment for HIV infected and uninfected tuberculosis patients: cohort study in rural South Africa. AIDS 1999; 13:811-817.
7. Wilkinson D, Davies GR. Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Trop Med Int Health 1997;2:700-704.
8. Hopewell P, Cynamon M, Starke J, Iseman M, O'Brien R. General guidelines for the evaluation of new antimicrobial drugs for the treatment of systemic mycobacterial infections. Clin Infect Dis 1992;15:S282-S295.
9. Perriens JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995;332:779-784.
10. Chan SL. Chemotherapy of tuberculosis. In Clinical tuberculosis. Edited by Davies PDO. London: Chapman & Hall; 1994:141-156.
11. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Resp Dis 1986;133:865-866.
12. Wilkinson D, Pillay M, Crump J, et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997;2:747-753.
13. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS 1997;11(Suppl B):S115-S123.
14. Gilks C, Floyd K, Haran D, et al. Care and support for people with HIV/AIDS in resource-poor settings. London: Department for International Development; 1998.